United Therapeutics (UTHR) Tops Q2 EPS by 67c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $549.90 +1.02%
EPS Growth %: +12.6%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +12.6%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $5.24, $0.67 better than the analyst estimate of $4.57. Revenue for the quarter came in at $596.5 million versus the consensus estimate of $524.18 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
- Qualcomm unveils Dragonfly CPU, signs Meta as first data center customer
- Paychex beats fourth quarter EPS estimates, stock slides
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
